Innovation for Health - 13 February 2020
Contact Investor Forum I4H Bootcamp
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare

Cillian King

Swanbridge Capital

Investment Manager, Swanbridge Capital
Cillian joined Swanbridge Capital in 2018 following a career in consultancy for early-stage ventures in the Life Sciences industry. As a consultant, Cillian gained extensive experience in the valuation of novel healthcare technologies, business development, project management, and non-dilutive funding.
In addition to working with early-stage ventures, Cillian was also involved in setting up several Dutch investment funds, including Swanbridge Capital in 2016. Cillian has a background in Molecular Biology (VU University and MIT) and a PhD in Molecular Neuroscience (VU University).
At Swanbridge Capital, Cillian is responsible for sourcing and evaluating investment proposals, deal making, and the management of portfolio companies.

About Swanbridge Capital
Swanbridge Capital is a Rotterdam based venture capital fund that actively invests in young, high potential companies in the life sciences. We focus on companies that are in very early stage in their development of therapeutics, diagnostics or medical devices in the proof of concept phase. Early stage investments usually require more than just a financial investment. Our involvement goes beyond that by actively supporting our portfolio companies. Swanbridge Capital is in the position to provide the knowledge and network that young companies require to bring their technology and company to the next phase

Sponsors & Partners 2020
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Gold sponsor
Award sponsor
AXON Lawyers
You?
Become a Sponsor!
Powered by
Hyphen Projects
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.